GlaxoSmithKline’s diabetes drug Avandia will increase cardiac risks while Takeda’s Actos may reduce cardiac risks. These research results were published in the latest edition of Journal of the American Medical Association. The research was done on 14,000 patients in 4 clinical trials over 1 year period. Actos protect patients from [...]
Avandia may cause Heart disease
May 22, 2007 By Leave a Comment
According to the study published in New England Journal of Medicine, Avandia, drug used in Type2 diabetes, increases the risk of cardiac-related fatalities by 64 per cent % and heart attacks by 43%. Avandia (Rosiglitazone) is in use since 1999 to treat Type2 diabetes generally in combination with Metformin or Glimipride. The study [...]
Recent Comments